The oestrous/menstrual cycle results from an intricate orchestration of neurochemical and endocrine events acting at the central nervous system, anterior pituitary and ovary (Freeman, 1994; Hotchkiss and Knobil, 1994). GnRH neurones represent the final output pathway of the neural network that integrates a multitude of internal and environmental cues to regulate the secretion of LH and FSH from the anterior pituitary gland. Different patterns of pulsatile secretion of GnRH into the hypophyseal portal system, along with changes in the responsiveness of the pituitary gonadotrophs to GnRH, cause the changes in LH and FSH secretion observed over the oestrous cycle. The most marked of these changes is the massive outpouring of LH at mid-cycle, a critical event responsible for initiating ovulation.
GnRH, produced by a loose network of neurones in the basal forebrain, is the primary brain signal responsible for the release of LH and FSH from the anterior pituitary gland. The ovarian steroid hormone oestradiol feeds back at both the central nervous system and the anterior pituitary to regulate the patterns of release of GnRH and the gonadotrophins. Although recent evidence indicates that oestradiol may act directly on some GnRH neurones through classical genomic mechanisms, data from published studies have demonstrated that neurotransmission of afferent neuronal systems that are receptive to oestradiol is necessary to drive reproductive cyclicity. Many classical neurotransmitters and neuropeptides alter GnRH neuronal activity, through direct and sometimes indirect actions. This review focuses on the neurotransmitters that regulate GnRH neurones by binding to and activating specific membrane receptors that are expressed in GnRH neurones. These include the catecholamines, γ-aminobutyric acid, glutamate, neuropeptide Y, neurotensin, β-endorphin and vasoactive intestinal polypeptide. On the basis of recent molecular and neuroanatomical evidence, it is proposed that oestradiol influences the activity of these neurotransmitter and neuropeptide systems within the GnRH network to drive reproductive cyclicity.
necessary to summarize the anatomical organization of the GnRH neuronal system in the adult rat brain (Jennes and Conn, 1994; Silverman et al., 1994) . GnRH cell bodies are not found in compact groups or clusters, but are arranged in loose networks (Fig. 1) . In rodents, GnRH cell bodies form a loose continuum from the medial septum and diagonal band of Broca to the ventral anterior hypothalamus. GnRH neurones send axonal projections to many sites within the brain; however, the major projection relevant to the control of anterior pituitary function extends to the external layer of the median eminence through periventricular and subventricular pathways. Here, GnRH is released into the fenestrated capillaries and is carried via the hypophyseal portal system to the anterior pituitary to regulate gonadotrophin secretion. Retrograde transport studies have demonstrated that, in rats, approximately 50-75% of all GnRH neurones project axons or axon collaterals to the median eminence. This percentage is likely to be an underestimate, since a single injection of retrograde tracer is probably unable to fill the entire GnRH terminal field in the median eminence.
Additional sites in which GnRH axons terminate next to fenestrated capillaries include the organum vasculosum of the lamina terminalis (OVLT) and the subfornical organ. However, since only a venous connection has been found between these regions and the anterior pituitary, the role and targets of GnRH released from these sites are not known. However, owing to the rapid degradation of the decapeptide in the blood (t 1 -2 = 2 min), the high dilution factor in the blood and a binding affinity for the GnRH receptor of about 5 nmol l -1 , these targets can be expected to be nearby. Less extensive GnRH pathways extend into the medial amygdala through the stria terminalis and the ventral amygdalofugal pathway as well as the periaqueductal central gray through periventricular radiations and the medial habenula-fasciculus retroflexus-interpenduncular nucleus pathway. It should be noted that studies using electron microscopy have shown that GnRH is contained in presynaptic terminals in many of these regions, indicating a role as neuromodulator or neurotransmitter in the above terminal fields.
Ultrastructural analyses of GnRH neurones have revealed several morphological features that may have important functional implications. For example, the synaptic input to GnRH neurones is very limited compared with other neurones in the preoptic area (Jennes and Conn, 1994; Silverman et al., 1994) . It has been estimated that about 0.4% of the surface area GnRH perikaryon is occupied by presynaptic specialization compared with 6.6% of neighbouring cells. This percentage corresponds to approximately five to seven synapses per GnRH perikaryon. Thus, the neurotransmitters and neuropeptides that communicate directly with GnRH neurones through synapses probably exert quite a powerful effect on GnRH neuronal activity. An alternative explanation is that direct presynaptic inputs to GnRH nerve terminals at the level of the median eminence play a more crucial role in determining the activity of the GnRH neurones. However, evidence is limited in this regard and additional research is necessary.
GnRH neurones are enveloped by thin glial sheaths and it can be envisioned that such sheaths could prevent axon terminals from forming temporary synaptic complexes with the plasma membrane of the GnRH neurones. Such a scenario is reminiscent of the neurohypophyseal system in which pituicytes can separate temporarily the oxytocin-and vasopressin-containing nerve terminals from the site of release into the perivascular space (Hatton et al., 1984) . At present it is not clear whether, in rats, dynamic changes occur in the degree of glial ensheathment of GnRH neurones under various endocrine conditions, as has been described for monkeys (Romero et al., 1994) . However, ovariectomy induces morphological changes in the physical contact between GnRH axon terminals and the basal lamina of fenestrated capillaries in the median eminence (King and Letourneau, 1994) .
The role of oestradiol in the induction of the preovulatory LH surge and subsequent ovulation is well recognized (Herbison, 1998) . However, owing to the paucity of information on the temporal and spatial nature of its interaction in the central nervous system, the exact nature of the influence of oestradiol on GnRH neurones remains undetermined. For the past two decades, it was thought that the actions of oestradiol on GnRH neurones were indirect and that oestradiol altered GnRH neuronal activity by activating or inhibiting afferent neurones. This view was based on the inability of immunocytochemical studies to detect oestrogen receptor protein consistently in GnRH neurones of a number of species, as well as on the lack of accumulation of radioactive oestrogen in nuclei of GnRH neurones in vivo. Recent evidence based on improvements in the sensitivity of the methods indicates that some GnRH neurones may contain oestrogen receptors (Skynner et al., 1999; Hrabovsky et al., 2000) . Large discrepancies are apparent among these studies and, therefore, there is no concrete evidence for the direct regulation of GnRH neurones by oestradiol. However, it is clear that afferent input to GnRH neurones is required for the maintenance of cyclic GnRH secretion, since treatments with specific antagonists to several key neurotransmitters and neuropeptides abolish the preovulatory LH surge (Kalra, 1993; Kordon et al., 1994) .
Because of the substantial amount of physiological and pharmacological evidence in support of multiple controls of GnRH and LH release by neurotransmitters and neuropeptides, the nature of synaptic inputs to GnRH neurones has received a great deal of attention. A number of studies using dual-label immunohistochemistry and in situ hybridization histochemistry has shown that several neurotransmitter and neuropeptide receptor mRNAs and proteins are expressed in GnRH neurones, including receptors for catecholamines, γ-aminobutyric acid (GABA), glutamate, neuropeptide Y, neurotensin and vasoactive intestinal polypeptide (VIP) ( Table 1) .
Direct regulation of oestrogen-dependent GnRH neural activity by brainstem catecholamines and indolamines
Extensive evidence indicates that noradrenaline, adrenaline and 5-hydroxytryptamine, which originate from neurones in the brainstem, play a stimulatory role in the regulation of GnRH neuronal functioning.
Noradrenaline and adrenaline
Destruction of noradrenaline neurones in the brainstem or local inhibition of α-adrenergic receptors decreases pulsatile tonic secretion of LH as well as cyclic LH release during the LH surge. However, the precise mechanisms by which the noradrenergic neurones drive GnRH secretion are not completely understood. Noradrenaline appears to allow or promote interactions between other neurones that, in turn, alter GnRH neuronal functioning (Herbison, 1997a) . Support for this hypothesis arises from the observation that lesion of the noradrenaline neuronal system abolishes the LH surge for several weeks before cyclicity is reinstated. These experiments also reveal the principle that there are compensatory mechanisms or redundancies in the brain that can take over the neuroendocrine control of the reproductive cycle.
Noradrenaline may also play a role in mediating part of the stimulatory effects of oestradiol on GnRH secretion during the preovulatory period (Herbison, 1997a) . Serum oestradiol concentrations correlate with noradrenaline turnover or release in regions of the hypothalamus that regulate GnRH synthesis or release at the time of the preovulatory LH surge (Mohankumar et al., 1994) . Noradrenergic neurones are direct targets for oestradiol and since the percentage of noradrenaline neurones in the A2 cell group expressing Fos (an indicator of neuronal activity) increases in pro-oestrus before the onset of the preovulatory LH surge, it is suggested that oestradiol directly activates transcription or transmitter release in these neurones.
Most of the studies on the role of noradrenaline in the control of GnRH secretion have used α-adrenergic receptor antagonists as well as inhibitors of dopamine-β-hydroxylase activity and it is thus possible that the observed effects on GnRH release were actually caused by adrenaline. This view is supported by the finding that both noradrenaline and adrenaline are contained in axons that are juxtaposed to GnRH neurones in the septum-diagonal band. Although certain aspects of the role of adrenaline remain controversial, most studies have demonstrated that adrenaline also stimulates both pulsatile and preovulatory release of GnRH. Adrenaline is important in regulating LH pulse frequency, whereas noradrenaline stimulated both the amplitude and frequency of LH pulses (Gallo et al., 1989) . Furthermore, inhibition of adrenaline synthesis, in the presence of adequate noradrenaline concentrations, prevents the prooestrous LH surge.
Recent studies have begun to decipher the exact catecholaminergic pathways through which oestradiol affects GnRH neuronal activity. Retrograde tracing techniques revealed that noradrenergic neurones projecting to the immediate vicinity of the GnRH cell bodies in the rostral preoptic area appear to be located exclusively in the ventrolateral medulla (A1 cell group) and the nucleus tractus solitarii (A2 cell group) (Wright and Jennes, 1993a).
Only the A2 noradrenergic neurones that project to the preoptic area express oestrogen receptor protein, whereas the A1 neuronal afferents do not (Simonian et al., 1999) . With respect to adrenaline, most hypothalamic nuclei receive adrenergic afferents from all three cell groups (that is, C1, C2 and C3) in the medulla, although their relative contributions vary. Lee et al. (2000) demonstrated that many adrenergic neurones in all cell groups express oestrogen receptors and that a significant percentage of adrenergic neurones in the brainstem express Fos during the initiation of the steroid-induced LH surge. Additional work is necessary to determine whether the adrenergic neurones that project to the vicinity of GnRH cell bodies are the neurones that also contain oestrogen receptor α protein.
In rats, noradrenergic and adrenergic axons are present in large numbers in the rostral preoptic area and the medial septum-diagonal band of Broca region, in which most GnRH neurones are located (Wright and Jennes, 1993a; Fig. 2) , and some of the tyrosine hydroxylase immunoreactive terminals form presynaptic terminals on GnRH neurones. That these synapses are functional is indicated by the finding that many GnRH neurones express the α 1B -adrenergic receptor subtype at the cell body and to a lesser extent at the nerve terminal in the median eminence (Hosny and Jennes, 1998; Fig. 3 ). However, since the α 1B -adrenergic receptor protein is frequently localized to sites on the GnRH neurones that are not in close apposition to noradrenergic or adrenergic axons, asynaptic release of the catecholamines followed by diffusion to the receptors is indicated. In addition, Lee et al. (1995) reported the presence of α 2A -adrenergic receptors in GnRH neurones. However, it should be noted that, thus far, the stimulatory influence of noradrenaline on GnRH neuronal activity has been attributed only to the α 1 -adrenergic receptors.
5-Hydroxytryptamine
5-Hydroxytryptamine (5HT), synthesized by neurones in the raphe nuclei, plays an important role in the generation of the LH surge (Kordon et al., 1994) acting through the 5HT 2A receptor (Fink et al., 1999) . Serotonergic activity is regulated by ovarian steroids, since treatment of ovariectomized rats with oestrogen and progesterone significantly increases 5HT concentrations in the preoptic area and hypothalamus. Furthermore, a significant proportion of serotonergic cell bodies in the median raphe nucleus (Leranth et al., 1999) , but not the dorsal raphe nucleus (Alves et al., 1998), express oestrogen receptor β immunoreactivity. It is not clear whether the effects of 5HT on GnRH release are caused by direct actions on GnRH neurones or whether other interneurones are involved, since anatomical studies have shown that only about 5% of nerve terminal boutons apposed to GnRH neurones are serotonergic and dual in situ hybridization studies have failed to detect mRNA for 5HT 1A, 5HT 1C and 5HT 2 receptors in GnRH neurones (Wright and Jennes, 1993b).
Direct regulation of oestrogen-dependent GnRH neural activity by local circuits
Much of the regulation of GnRH neurones appears to be accomplished by local circuits. Anatomical studies have demonstrated that extensive, oestrogen-sensitive afferent projections to the vicinity of GnRH neurones originate from cell bodies residing within the preoptic area and hypothalamus, particularly the arcuate nucleus (Simonian et al., 1999). The major neurotransmitters and neuropeptides in this category include excitatory amino acids, GABA, neurotensin, neuropeptide Y, β-endorphin and VIP.
Excitatory amino acids
Neurotransmission of excitatory amino acids in the brain principally involves glutamate and aspartate. Excitatory amino acids induce a rapid increase in GnRH or LH release and enhance GnRH mRNA and protein content (Brann and Mahesh, 1997), whereas inhibition of the different glutamate receptor subunit families has the converse effect. Increased glutamate and aspartate release in the preoptic region slightly precedes or parallels the LH surge.
Glutamatergic input to the GnRH neuronal system is likely Direct regulation of GnRH secretion to be mediated by direct synapses at the GnRH cell bodies or dendrites, as has been described in monkeys, or by asynaptic neurotransmission at the median eminence (Kawakami et al., 1998) . In further support of a direct action of excitatory amino acids on GnRH neurones, kainic acid 2 (KA 2 ) receptor mRNA and protein is present in approximately 50% of all GnRH neurones, and the KA 2 -receptor protein is preferentially expressed in GnRH neurones that synthesize c-Fos during the LH surge (Eyigor and Jennes, 1996, 2000; Fig. 4) . Whereas several investigators have reported that only approximately 5% of all GnRH neurones express NMDAR 1 mRNA (Abbud and Smith, 1995; Eyigor and Jennes, 1996) , a recent publication indicates that approximately 80% of all GnRH neurones may express this particular receptor subtype (Ottem and Petersen, 2000) . Spergel et al. (1999) demonstrated that glutamate evoked currents in GnRH neurones in mice, providing strong evidence that these neurones express functional glutamate receptors. Glutamate neurones in the hypothalamus are regulated in part by oestrogen. Thus, glutamate content is increased after short-term treatment with oestradiol and the steroid treatment is required for glutamate to exert a stimulatory effect on LH secretion. These effects of oestrogen on glutamate neurones appear to be mediated by binding to, and activation of, nuclear oestrogen receptor α protein that is expressed in many hypothalamic glutamatergic neurones, especially in the preoptic region (C. T. Moore and L. Jennes, unpublished).
γ-Aminobutyric acid (GABA)
GABA, the major inhibitory neurotransmitter of the brain, plays an important role in the regulation of GnRH secretion. Removal of GABAergic tone on the afternoon of pro-oestrus is an important neural signal for the generation of the LH surge (Kimura and Jinnai, 1994) . Extracellular GABA concentrations in the medial preoptic area, but not in the medial basal hypothalamus, decrease before and during the LH surge induced by oestradiol in ovariectomized rats (Jarry et al., 1995) . The co-localization of oestrogen receptor α in preoptic GABAergic cell bodies as well as the effects of oestradiol on GABA release, re-uptake and GABA A receptor gene expression indicate that the GABAergic neuronal network in the rostral hypothalamus is extremely sensitive to circulating concentrations of oestradiol (Herbison, 1997b) . Thus, oestrogen decreases the hyperpolarizing response of GABAergic neurones to GABA B receptor agonists for at least 24 h and it reduces glutamic acid decarboxylase mRNA content after 42 h but not after 24 h. These data indicate that oestrogen reduces the autoinhibition of GABAergic neurones 6 M. J. Smith and L. Jennes during negative feedback conditions, whereas during positive oestrogen feedback conditions GABAergic activity is reduced (Wagner et al., 2001) . GABA probably inhibits GnRH release through a direct action on GnRH neurones since nerve terminals containing glutamic acid decarboxylase (GAD), the enzyme responsible for GABA synthesis, make synaptic contacts with GnRH cell bodies in the rat medial preoptic area, and a significant proportion of GnRH neurones express mRNA for GABA A (Petersen et al., 1993; Jung et al., 1998) and GABA B (S. L. Petersen, personal communication) receptors. Recent electrophysiological studies (Spergel et al., 1999; Sim et al., 2000) have shown that all GnRH neurones in mice express functional GABA A receptors, which underlines the importance of this neurotransmitter in the control of GnRH neurones.
Neuropeptide Y Neuropeptide Y, a 36 amino acid peptide, facilitates GnRH release and potentiates the responsiveness of gonadotrophs to GnRH (Kalra, 1993; Herbison, 1998) . Neuropeptide Y innervation of the hypothalamus and preoptic area originates from two discrete cell populations, one in the arcuate nucleus and the other in the brainstem, in which neuropeptide Y is co-localized with noradrenaline. In rats, approximately 15% of neuropeptide Y neurones in the arcuate nucleus express oestrogen receptor α, whereas the neuropeptide Y neurones in the brainstem do not (Simonian and Herbison, 1997) . Neuropeptide Y gene expression appears to be regulated in part by oestrogen since synthesis and release of the peptide are high before the pro-oestrous LH surge (Sahu and Kalra, 1998) . Although neuropeptide Y influences pulsatile LH release, most attention has focused on involvement of neuropeptide Y in the generation of the LH surge. Thus, immunoneutralization of neuropeptide Y or inhibition of neuropeptide Y synthesis with antisense oligonucleotides prevents the LH surge in steroid-treated rats. Neuropeptide Y-containing terminals originating in both the arcuate nucleus and brainstem project to the median eminence and to the septum-preoptic region, in which some immunoreactive axons make synaptic contacts with GnRH cell bodies and processes. The functional significance of neuropeptide Y innervation of GnRH neurones is not clear at present, since there is no convincing evidence for the co-localization of neuropeptide Y1 receptors in GnRH perikarya and the receptor is only found in certain GnRH terminals in the median eminence (Li et al., 1999) .
Neurotensin
Neurotensin is found in many neurones of the preoptic area and numerous studies indicate that this peptide mediates the stimulatory effects of oestrogen on GnRH secretion (Rostene and Alexander, 1997; Herbison, 1998) . Administration of neurotensin amplifies, whereas immunoneutralization reduces, the magnitude of the LH surge. In addition, a large proportion of neurotensincontaining neurones in the preoptic area express oestrogen receptors and oestradiol stimulates neurotensin gene expression in this region.
The ability of neurotensin neurones in the preoptic area to stimulate GnRH neuronal activity appears to be mediated, at least in part, by direct communication with GnRH neurones. Neurotensin immunoreactive fibres closely appose GnRH neurones in mice (Hoffman, 1985) . Neurotensin exerts its effects through at least three receptors that have been cloned and designated NT1 (high affinity), nt2 and nt3. Only NT1 is thought to mediate the physiological effects of neurotensin (Rostene and Alexander, 1997) . Smith and Wise (in press) demonstrated that some GnRH neurones in the OVLT/rPOA express mRNA for the NT1 receptor.
Endogenous opioid peptides
Endogenous opioid peptides constitute an important inhibitory component of the neural circuitry that regulates GnRH secretion, and a significant decrease in the inhibitory opioid tone is critical for the generation of the LH surge (Kalra, 1993) . Evidence from published studies supports a role for β-endorphin acting via µ-opioid receptors in transmitting information about the steroidal milieu to GnRH neurones. Cell bodies containing β-endorphin are located exclusively in the periarcuate region of the medial basal hypothalamus, and a small percentage of these neurones concentrate oestradiol in their nuclei.
Nerve terminals containing β-endorphin synapse on Direct regulation of GnRH secretion 7 perikarya and dendrites of GnRH neurones in rats; however, opioid receptor mRNAs (that is µ, δ and κ) have not been found in GnRH neurones (Mitchell et al., 1997; Sannella and Petersen, 1997) . However, the receptors are present in many cells within the preoptic area and hypothalamus, which indicates that β-endorphin may influence GnRH neurones through inhibition of interneurones. It should be noted that Eckersell and Micevych (1998) identified µ-and δ-opioid receptor immunoreactivity in GnRH fibres throughout the hypothalamus; however, the GnRH perikarya did not show such immunoreactivity.
Vasoactive intestinal polypeptide (VIP)
Oestradiol drives the hypersecretion of GnRH by coupling a circadian neuronal signal from the suprachiasmatic nucleus (SCN) to the neurotransmitters and neuropeptides that regulate GnRH secretion. The precise mechanisms by which the SCN transmits circadian information to the GnRH neuronal network are not known. However, recent evidence indicates that VIP, synthesized in the ventrolateral aspect of the SCN, is a critical neurochemical messenger that relays time-of-day information from the SCN to GnRH neurones (van der Beek, 1996) . Thus, infusion of VIP antisense oligonucleotides directly into the SCN (Harney et al., 1996) or central administration of antiserum to VIP (van der Beek et al., 1999) delays and attenuates the steroid-induced LH surge. In addition, morphological studies have shown that VIPcontaining fibres closely appose GnRH cell bodies and dendrites, and that this input to GnRH neurones originates in the SCN. A substantial proportion of the GnRH neurones that receive VIP input express c-Fos during the afternoon of prooestrus, which indicates that these neurones are activated. Approximately 40% of all GnRH neurones express the VIP 2 receptor protein (Smith et al., 2000; Fig. 5) , indicating that most of the VIP input to GnRH is direct and probably synaptic. Whether oestradiol has a direct influence on VIP neuronal activity is not known, although oestrogen receptor β is expressed in low amounts in the SCN.
Conclusions
At present, it is clear that oestradiol, coupled with a daily neural signal originating from the SCN, orchestrates the activity of a number of neurotransmitter and neuropeptide systems resulting in a cyclical activation of the GnRH network (Fig. 6) . It is apparent that each of these neural components, either acting in series or in parallel with one another, must be functional for the GnRH/LH surge to occur, since the acute pharmacological manipulation of any one of these components prevents the GnRH/LH surge. This review has focused on those neuromodulators that alter GnRH neuronal activity directly by binding to membrane receptors present on GnRH perikarya; much remains to be learned about other potential participants and the precise mechanisms by which oestradiol communicates with these messenger systems.
